Literature DB >> 1733627

Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.

A A Khamlichi1, P Aucouturier, C Silvain, M Bauwens, G Touchard, J L Preud'homme, F Nau, M Cogné.   

Abstract

Previous data suggest that structural abnormalities of immunoglobulin light chains may be responsible for non-amyloid light chain deposition disease (LCDD). We report on the complete primary sequence deduced from complementary (c)DNA analysis of a normal-sized kappa chain in a case of myeloma-associated LCDD. The patient's urine contained a kappa type Bence-Jones protein made of monomers and dimers of an unglycosylated kappa chain. The bone marrow myeloma cells contained intracellular kappa and gamma chains by immunofluorescence. Biosynthesis experiments showed the production of normal-sized gamma chains and of kappa chains with the same apparent molecular mass (Mr) in SDS gels as the urinary kappa chain (26,000-27,000). These kappa chains were secreted as assembled IgG molecules and as a large excess of free monomers and dimers. The complete sequence of two identical cDNA clones derived from a normal-sized kappa messenger RNA indicated that this kappa chain belonged to the rare V kappa IV subgroup. The kappa mRNA had an overall normal structure made up of the V kappa IV sequence rearranged to J kappa 1 and followed by a normal constant exon of the Km(3) allotype. The variable region differed from the V kappa IV-J kappa 1 germline sequence by 17 amino acid substitutions. The peculiar sequence of the variable region of this kappa chain of a rare subgroup might relate to its tissue deposition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733627      PMCID: PMC1554240          DOI: 10.1111/j.1365-2249.1992.tb06424.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.

Authors:  M Cogné; J L Preud'homme; M Bauwens; G Touchard; P Aucouturier
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis.

Authors:  J N Buxbaum; J V Chuba; G C Hellman; A Solomon; G R Gallo
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

3.  Subgroup IV of human immunoglobulin K light chains is encoded by a single germline gene.

Authors:  H G Klobeck; G W Bornkamm; G Combriato; R Mocikat; H D Pohlenz; H G Zachau
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

4.  Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization.

Authors:  M M Picken; B Frangione; B Barlogie; M Luna; G Gallo
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Renal transplantation in light chain nephropathy: case report and review of the literature.

Authors:  P G Gerlag; R A Koene; J H Berden
Journal:  Clin Nephrol       Date:  1986-02       Impact factor: 0.975

6.  Canonical structures for the hypervariable regions of immunoglobulins.

Authors:  C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

Review 7.  The spectrum of monoclonal immunoglobulin deposition disease associated with immunocytic dyscrasias.

Authors:  G Gallo; M Picken; J Buxbaum; B Frangione
Journal:  Semin Hematol       Date:  1989-07       Impact factor: 3.851

8.  Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.

Authors:  M Cogné; A Bakhshi; S J Korsmeyer; P Guglielmi
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

9.  Evolution of human immunoglobulin kappa J region genes.

Authors:  P A Hieter; J V Maizel; P Leder
Journal:  J Biol Chem       Date:  1982-02-10       Impact factor: 5.157

10.  Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition.

Authors:  J L Preud'homme; L Morel-Maroger; J C Brouet; M Cerf; F Mignon; P Guglielmi; M Seligmann
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

View more
  9 in total

1.  Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.

Authors:  R Vidal; F Goñi; F Stevens; P Aucouturier; A Kumar; B Frangione; J Ghiso; G Gallo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein.

Authors:  M A Alim; S Yamaki; M S Hossain; K Takeda; M Kozima; T Izumi; I Takashi; T Shinoda
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

3.  Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.

Authors:  A Rocca; A A Khamlichi; P Aucouturier; L H Noël; L Denoroy; J L Preud'homme; M Cogné
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

Review 4.  Molecular anatomy and the pathological expression of antibody light chains.

Authors:  M Schiffer
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

5.  Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.

Authors:  G Gallo; F Goñi; F Boctor; R Vidal; A Kumar; F J Stevens; B Frangione; J Ghiso
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor.

Authors:  Magali Colombat; Hervé Mal; Christiane Copie-Bergman; Jacques Diebold; Diane Damotte; Patrice Callard; Michel Fournier; Jean-Pierre Farcet; Marc Stern; Marie-Hélène Delfau-Larue
Journal:  Blood       Date:  2008-05-15       Impact factor: 22.113

7.  Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease.

Authors:  C Decourt; G Touchard; J L Preud'homme; R Vidal; H Beaufils; M C Diemert; M Cogné
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

8.  Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.

Authors:  Haruki Hasegawa
Journal:  Int J Cell Biol       Date:  2013-03-05

9.  Analysis of Urine Composition in Type II Diabetic Mice after Intervention Therapy Using Holothurian Polypeptides.

Authors:  Yanyan Li; Jiajie Xu; Xiurong Su
Journal:  Front Chem       Date:  2017-07-26       Impact factor: 5.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.